Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5762_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Contents
- •1.1 Historical Remarks
- •1.1.1 Contrast Enhanced Ultrasound
- •2.2 Machine Settings
- •1.4 CEUS Phases
- •1.8 Three-Dimensional (3D) CEUS
- •1.9 CEUS Guidelines
- •References
- •2.1 Introduction
- •2.2.2 Image Depth Penetration
- •2.2.3 Focus
- •2.2.5 Background Signal (Noise)
- •2.2.6 Dynamic Range
- •2.2.7 Frame Rate
- •2.6 Artifacts
- •2.6.1 Long Liver Enhancement
- •2.7 Safety
- •References
- •3.1 Introduction
- •3.7 Detection by Intraoperative Contrast Enhanced Ultrasound (IO-CEUS)
- •References
- •4: Malignant Liver Tumors
- •4.1 Hepatocellular Carcinoma
- •4.1.1 Introduction
- •4.1.6 Surveillance
- •4.1.7 CEUS LI-RADS
- •4.1.8 Small HCC
- •4.1.9 Treatment Response Follow Up
- •4.1.9.1 Ablation Therapy
- •4.1.9.2 Transarterial Chemoembolization
- •4.1.9.3 Targeted Therapy
- •4.2 Intrahepatic Cholangiocarcinoma
- •4.2.2 Imaging
- •4.2.2.1 Conventional Ultrasound Findings
- •4.2.2.2 Contrast Enhanced Ultrasound Findings
- •4.2.2.3 CT Findings
- •4.2.2.4 MRI Findings
- •4.2.2.5 Other Imaging Findings
- •4.2.2.6 Best Imaging Protocol Advices
- •4.2.3.1 Hepatocellular Carcinoma
- •4.2.4 Pathology
- •4.2.4.1 General Features
- •4.2.5 Clinical Issues
- •4.2.5.1 Presentation
- •4.2.5.2 Prognosis
- •4.2.5.3 Treatment
- •4.3 Liver Metastases
- •4.3.1 Terminology
- •4.3.2 Imaging Features
- •4.3.2.1 Conventional Ultrasound Findings
- •4.3.2.2 Contrast Enhanced Ultrasound Findings
- •4.3.2.3 CT Findings
- •4.3.2.4 MRI Findings
- •4.3.3.1 Hepatocellular Carcinoma
- •4.3.3.2 Intrahepatic Cholangiocarcinoma
- •4.3.3.3 Focal Fatty Liver Change
- •4.4 Dysplasia Nodules
- •4.4.1 Terminology
- •4.4.2 Imaging
- •4.4.2.1 Conventional Ultrasound Findings
- •4.4.2.2 Contrast Enhanced Ultrasound Findings
- •4.4.2.3 CT Findings
- •4.4.2.4 MRI Findings
- •4.4.2.5 Best Imaging Protocol Advices
- •4.4.4 Pathology
- •4.4.4.1 General Features
- •4.4.5 Clinical Issues
- •4.4.5.1 Presentation
- •4.4.5.2 Prognosis
- •4.4.5.3 Treatment
- •References
- •5: Benign Liver Tumors
- •5.1 Hepatic Hemangioma
- •5.1.1 Terminology
- •5.1.2 Imaging
- •5.1.2.1 Conventional Ultrasound Findings
- •5.1.2.2 Contrast Enhanced Ultrasound Findings
- •5.1.2.3 CT Findings
- •5.1.2.4 MRI Findings
- •5.1.2.5 Other Imaging Findings
- •5.1.2.6 Best Imaging Protocol Advices
- •5.1.3.1 Hepatocellular Carcinoma
- •5.1.3.2 Metastatic Hepatic Carcinoma
- •5.1.3.3 Focal Angiosarcoma
- •5.1.3.4 Abscess
- •5.1.3.5 Hepatic Adenoma
- •5.1.4 Pathology
- •5.1.4.1 General Features
- •5.1.5 Clinical Issues
- •5.1.5.1 Presentation
- •5.1.5.2 Prognosis
- •5.1.5.3 Treatment
- •5.2 Focal Nodular Hyperplasia
- •5.2.1 Terminology
- •5.2.2 Imaging
- •5.2.2.1 Conventional Ultrasound Findings
- •5.2.2.2 Contrast Enhanced Ultrasound Findings
- •5.2.2.3 CT Findings
- •5.2.2.4 MRI Findings
- •5.2.2.5 Other Imaging Findings
- •5.2.2.6 Best Imaging Protocol Advices
- •5.2.3.1 Hepatic Adenoma
- •5.2.3.2 Hepatocellular Carcinoma
- •5.2.3.3 Fibrolamellar Hepatocellular Carcinoma
- •5.2.4 Pathology
- •5.2.4.1 General Features
- •5.2.5 Clinical Issues
- •5.2.5.1 Prognosis
- •5.2.5.2 Treatment
- •5.3 Hepatocellular Adenoma
- •5.3.1 Terminology
- •5.3.2 Imaging
- •5.3.2.1 Ultrasonographic Findings
- •5.3.2.2 Contrast Enhanced Ultrasound Findings
- •5.3.2.3 CT Findings
- •5.3.2.4 MRI Findings
- •5.3.2.5 Imaging Recommendations
- •5.3.3.1 Focal Nodular Hyperplasia
- •5.3.3.2 Hepatocellular Carcinoma
- •5.3.3.3 Fibrolamellar Hepatocellular Carcinoma
- •5.3.3.4 Hepatic Hemangioma
- •5.3.4 Pathology
- •5.3.4.1 General Features
- •5.3.5 Clinical Issues
- •5.3.5.1 Presentation
- •5.3.5.2 Complications
- •5.4.1 Terminology
- •5.4.2 Imaging
- •5.4.2.1 Conventional Ultrasound Findings
- •5.4.2.2 Contrast Enhanced Ultrasound Findings
- •5.4.2.3 CT Findings
- •5.4.2.4 MRI Findings
- •5.4.2.5 Other Imaging Findings
- •5.4.2.6 Best Imaging Protocol Advices
- •5.4.3.1 Hepatocellular Carcinomas
- •5.4.3.2 Metastases
- •5.4.3.3 Hemangioma
- •5.4.4 Pathology
- •5.4.4.1 General Features
- •5.4.5 Clinical Issues
- •5.4.5.1 Presentation
- •5.4.5.2 Prognosis
- •5.4.5.3 Treatment
- •References
- •6: Rare Malignant Liver Tumors
- •6.1 Hepatic Lymphoma
- •6.1.1 Terminology
- •6.1.2 Imaging
- •6.1.2.1 Conventional Ultrasound Findings
- •6.1.2.2 Contrast Enhanced Ultrasound Findings
- •6.1.2.3 CT Findings
- •6.1.2.4 MRI Findings
- •6.1.2.5 Other Imaging Findings
- •6.1.2.6 Best Imaging Protocol Advices
- •6.1.4 Pathology
- •6.1.4.1 General Features
- •6.1.5 Clinical Issue
- •6.1.5.1 Presentation
- •6.1.5.2 Prognosis
- •6.1.5.3 Treatment
- •6.2.1 Terminology
- •6.2.2 Imaging
- •6.2.2.1 General Features
- •6.2.2.2 Conventional Ultrasound Findings
- •6.2.2.3 Contrast Enhanced Ultrasound Findings
- •6.2.2.4 CT Findings
- •6.2.2.5 MRI Findings
- •6.2.2.6 Other Imaging Findings
- •6.2.2.7 Imaging Recommendations
- •6.2.4 Pathology
- •6.2.4.1 General Features
- •6.2.5 Clinical Issues
- •6.2.5.1 Presentation
- •6.2.5.2 Prognosis
- •6.2.5.3 Treatment
- •6.3.1 Terminology
- •6.3.2 Imaging
- •6.3.2.1 Conventional Ultrasound Findings
- •6.3.2.3 Computed Tomography Findings
- •6.3.2.4 Magnetic Resonance Imaging Findings
- •6.3.2.5 Nuclear Medicine Findings
- •6.3.2.6 Imaging Recommendations
- •6.3.3.1 Focal Nodular Hyperplasia
- •6.3.3.2 Hepatocarcinoma
- •6.3.3.4 Hepatoadenoma
- •6.3.3.5 Intrahepatic Cholangiocarcinoma
- •6.3.4 Pathology
- •6.3.4.1 General Features
- •6.3.5 Clinical Issues
- •6.3.5.1 Presentation
- •6.3.5.2 Prognosis
- •6.3.5.3 Treatment
- •6.4 Hepatic Biliary Cystadenocarcinoma
- •6.4.1 Terminology
- •6.4.2 Imaging
- •6.4.2.1 Conventional Ultrasound Findings
- •6.4.2.2 Contrast Enhanced Ultrasound Findings
- •6.4.2.3 CT Findings
- •6.4.2.4 MRI Findings
- •6.4.2.5 Other Imaging Findings
- •6.4.2.6 Best Imaging Protocol Advices
- •6.4.3.1 Hepatic Biliary Cystadenoma
- •6.4.3.2 Simple Hepatic Cysts
- •6.4.3.3 Hemorrhagic Hepatic Cysts
- •6.4.3.4 Metastatic Tumor
- •6.4.3.5 Hepatic Abscesses
- •6.4.3.6 Hydatid Disease
- •6.4.3.9 Mesenchymal Hamartoma
- •6.4.4 Pathology
- •6.4.4.1 General Features
- •6.4.5 Clinical Issues
- •6.4.5.1 Presentation
- •6.4.5.2 Prognosis
- •6.4.5.3 Treatment
- •6.5 Neuroendocrine Neoplasm
- •6.5.1 Terminology
- •6.5.2 Image
- •6.5.2.1 Ultrasonographic Findings
- •6.5.2.2 Contrast Enhanced Ultrasound Findings
- •6.5.2.3 CT Findings
- •6.5.2.4 MR Findings
- •6.5.2.5 Other Imaging Finding
- •6.5.2.6 Best Imaging Protocol Advices
- •6.5.3.1 Hepatocellular Carcinoma
- •6.5.3.2 Metastatic Hepatic Carcinoma
- •6.5.4 Pathology
- •6.5.4.1 General Features
- •6.5.5 Clinical Issues
- •6.5.5.1 Presentation
- •6.5.5.2 Prognosis
- •6.5.5.3 Treatment
- •6.6.1 Terminology
- •6.6.2 Imaging
- •6.6.2.1 Conventional Ultrasound Findings
- •6.6.2.2 Contrast Enhanced Ultrasound Findings
- •6.6.2.3 CT Findings
- •6.6.2.4 MRI Findings
- •6.6.2.5 PET/CT Findings
- •6.6.2.6 Best Imaging Protocol Advices
- •6.6.3.1 Hepatocellular Carcinoma
- •6.6.3.2 Cholangiocarcinoma
- •6.6.3.3 Metastatic Liver Cancer
- •6.6.4 Pathology
- •6.6.5 Clinical Issues
- •References
- •7: Rare Benign Liver Tumors
- •7.1 Hepatic Angiomyolipoma
- •7.1.1 Terminology
- •7.1.2 Imaging
- •7.1.2.1 Conventional Ultrasound Findings
- •7.1.2.2 Contrast Enhanced Ultrasound Findings
- •7.1.2.3 CT Findings
- •7.1.2.4 MRI Findings
- •7.1.2.5 Other Imaging Findings
- •7.1.2.6 Best Imaging Protocol Advices
- •7.1.4 Pathology
- •7.1.4.1 General Features
- •7.1.5 Clinical Issues
- •7.1.5.1 Presentation
- •7.1.5.2 Prognosis
- •7.1.5.3 Treatment
- •7.2 Hepatic Biliary Cystadenoma
- •7.2.1 Terminology
- •7.2.2 Imaging
- •7.2.2.1 Conventional Ultrasound Findings
- •7.2.2.2 Contrast Enhanced Ultrasound Features
- •7.2.2.3 CT Findings
- •7.2.2.4 MRI Findings
- •7.2.2.5 Other Imaging Findings
- •7.2.2.6 Best Imaging Protocol Advices
- •7.2.3.1 Hepatic Biliary Cystadenocarcinoma
- •7.2.3.2 Simple Hepatic Cyst
- •7.2.3.3 Hemorrhagic Hepatic Cysts
- •7.2.3.4 Metastatic Tumor
- •7.2.3.5 Hepatic Abscesses
- •7.2.3.6 Hydatid Disease
- •7.2.3.9 Mesenchymal Hamartoma
- •7.2.4 Pathology
- •7.2.4.1 General Features
- •7.2.5 Clinical Issues
- •7.2.5.1 Presentation
- •7.2.5.2 Prognosis
- •7.2.5.3 Treatment
- •References
- •8: Hepatic Parasitosis
- •8.1 Terminology
- •8.1.1 Echinococcosis
- •8.1.2 Amebiasis
- •8.1.3 Schistosomiasis
- •8.2 Imaging
- •8.2.1 Conventional Ultrasound Findings
- •8.2.1.1 Echinococcosis
- •8.2.1.2 Amebiasis
- •8.2.1.3 Schistosomiasis
- •8.2.2 Contrast Enhanced Ultrasound Findings
- •8.2.2.1 Echinococcosis
- •8.2.3 CT Findings
- •8.2.3.1 Echinococcosis
- •8.2.3.2 Amebiasis
- •8.2.3.3 Schistosomiasis
- •8.2.4 MRI Findings
- •8.2.4.1 Echinococcosis
- •8.2.4.2 Amebiasis
- •8.2.4.3 Schistosomiasis
- •8.2.5 Other Imaging Findings
- •8.2.5.1 Echinococcosis
- •8.2.6 Best Imaging Protocol Advices
- •8.2.6.1 Echinococcosis
- •8.2.6.2 Amebiasis
- •8.2.6.3 Schistosomiasis
- •8.3 Pathology
- •8.3.1 General features
- •8.3.1.1 Echinococcosis
- •8.3.1.2 Amebiasis
- •8.3.2.1 Echinococcosis
- •8.4 Clinical Issues
- •8.4.1 Presentation
- •8.4.1.1 Echinococcosis
- •8.4.1.2 Amebic Liver Abscess
- •8.4.1.3 Schistosomiasis
- •8.4.2 Prognosis
- •8.4.2.1 Echinococcosis
- •8.4.2.2 Amebiasis
- •8.4.2.3 Schistosomiasis
- •8.4.3 Treatment
- •8.4.3.1 Echinococcosis
- •8.4.3.2 Amebiasis
- •8.4.3.3 Schistosomiasis
- •References
- •9: Hepatic Inflammatory Pseudotumor
- •9.1 Terminology
- •9.2 Imaging
- •9.2.1 Conventional Ultrasound Findings
- •9.2.2 Contrast Enhanced Ultrasound Findings
- •9.2.3 CT Findings
- •9.2.4 MRI Findings
- •9.2.5 Other Imaging Findings
- •9.2.6 Best Imaging Protocol Advices
- •9.3.1 Hepatocellular Carcinoma
- •9.3.2 Liver Metastasis Tumor
- •9.3.3 Intrahepatic Cholangiocarcinoma
- •9.3.4 Liver Abscess
- •9.4 Pathology
- •9.4.1 General Features
- •9.5 Clinical Issues
- •9.5.1 Presentation
- •9.5.2 Prognosis
- •9.5.3 Treatment
- •References
- •10: Hepatic Artery Aneurysm
- •10.1 Terminology
- •10.2 Hepatic Artery Aneurysm
- •10.3 Imaging
- •10.3.1 General Features
- •10.3.2 Radiographic Findings
- •10.3.3 DSA Findings
- •10.3.4 CT Findings
- •10.3.5 Conventional Ultrasound Findings
- •10.3.7 MRI Findings
- •10.3.8 Best Imaging Protocol Advices
- •10.3.9 Protocol Advice
- •10.5 Pathology
- •10.5.1 General Features
- •10.6 Clinical Issues
- •10.6.1 Presentation
- •10.6.2 Prognosis
- •10.6.3 Treatment
- •References
- •11: Peliosis Hepatis
- •11.1 Terminology
- •11.2 Imaging
- •11.2.1 Conventional Ultrasound Findings
- •11.2.2 Contrast Enhanced Ultrasound Findings
- •11.2.3 CT Findings
- •11.2.4 MRI Findings
- •11.2.5 Other Imaging Findings
- •11.2.6 Best Imaging Protocol Advices
- •11.3.1 Hepatic Adenoma
- •11.3.2 Hemangioma
- •11.3.3 Focal Nodular Hyperplasia
- •11.3.4 Hepatic Abscess
- •11.3.5 Hypervascular Metastases
- •11.3.6 Hepatocellular Carcinoma
- •11.3.7 Arteriovenous Malformations
- •11.4 Pathology
- •11.4.1 General Features
- •11.5 Clinical Issues
- •11.5.1 Presentation
- •11.5.2 Prognosis
- •11.5.3 Treatment
- •References
- •12.1 Introduction
- •12.8 Summary
- •References
- •References
- •14.1 Introduction
- •14.2 Indications
- •14.3 Equipment
- •14.4 3D-CEUS Procedures
- •14.5 Clinical Application
- •References
- •15: Future Prospects
- •15.2 Improved Liver Metastasis Detection (Sonazoid)
- •References

4 Malignant Liver Tumors
a b
c
47
e
Fig. 4.8 Images of contrast enhanced ultrasound (CEUS) LR-3, indeterminate malignancy probability, in a 39-year-old man with hepatitis
B-related cirrhosis. B mode ultrasound image showed a 9mm diameter
hyperechoic nodule located in right lobe of liver (a). The lesion showed
• Time intensity curves and quantitative evaluation of
dynamic CEUS parameters may provide additional
information in evaluations of the treatment effects of
anti- angiogenesis treatment. TTP may be an early and
sensitive parameter to evaluate response to sorafenib
treatment [13].
f
hyperenhancement during arterial phase both in 2D CEUS (b) and in
3D CEUS (c). The lesion was isoenhanced during portal venous phase
(d) and showed wash-out during late phase (e). Subsequent surgery and
histopathological results revealed a hepatocellular carcinoma (HCC)
• Three-dimensional CEUS (3D-CEUS) has recently been
successfully used to make accurate and clear depiction of
the tumor microvascular perfusion.
• A correlation has been proved to exist between 3D-CEUS
parameters and pathological changes in HCC after
treatment.

48
Y. Dong et al.
a
c
b
d
e
Fig. 4.9 Images of contrast enhanced ultrasound (CEUS) LR-4, probably hepatocellular carcinoma (HCC), in a 29-year-old man with hepatitis B-related cirrhosis. B mode ultrasound image showed a 17-mm
diameter hyperechoic nodule located in right lobe of liver (a). No color
ow signal could be detected inside the lesion (b). The lesion showed
nodular hyperenhancement during arterial phase in comparison with
f
the adjacent liver (c) and showed complete and quick hyperenhancement in 17s after injection of contrast agents (d). Mild wash-out was
observed during late portal venous (e) and late phase (f). Subsequent
surgery and histopathological results showed the lesion was a welldifferentiated stage II HCC

4 Malignant Liver Tumors
49
a
c
b
d
Fig. 4.10 Images of contrast enhanced ultrasound (CEUS) LR-5, denitely hepatocellular carcinoma (HCC), in a 45-year-old man with
hepatitis B-related cirrhosis. Surveillance US image shows a 15mm
diameter hypoechoic nodule (a). The lesion showed hyperenhancement
during arterial phase compared with the adjacent liver (b). CEUS image
4.2 Intrahepatic Cholangiocarcinoma
Pei-LiFan, FengMao, and Wen-PingWang
4.2.1 Denitions
Intrahepatic cholangiocarcinoma (ICC) is the second most
common primary hepatic malignant tumor after hepatocellular carcinoma (HCC). ICC is biliary epithelial differentiation and occurs in intrahepatic biliary tree, from the segmental
obtained 30 s after microbubble injection showed unequivocal slight
contrast wash-out (c). Obvious wash-out was observed during late
phase (d). Subsequent surgery and histopathological results showed the
lesion was a stage III HCC
ducts to the smallest bile ducts. ICC could be classied into
three types: mass-forming type, intraductal-growth type, and
periductal inltrating type. Mass-forming type is the most
common type of ICC [14, 15].
4.2.2 Imaging
4.2.2.1 Conventional Ultrasound Findings
Mass-forming type
The mass-forming type of ICC is an expansile mass lesion
with ill-dened border in the hepatic parenchyma (Fig.4.28).

50
a
cd
ef
Y. Dong et al.
b
g
Fig. 4.11 Images of contrast enhanced ultrasound (CEUS) LR-5, denitely hepatocellular carcinoma (HCC), in a 49-year-old man with
hepatitis B related cirrhosis. B mode ultrasound image showed a 13mm
diameter small hypoechoic nodule in the supercial area of right lobe of
liver (a). Color ow signals could be detected in the surrounding area of
the lesion (b). While using the high-frequency linear transducer, posterior hyperechoic could be observed on B mode ultrasound (c) with simi-
lar color ow signals (d). The lesion showed hyperenhancement during
arterial phase compared with the adjacent liver (e). CEUS image
obtained 60 s after microbubble injection showed isoenhancement.
Unequivocal slight contrast wash-out could be observed during late
phase (f). Subsequent surgery and histopathological results showed the
lesion was a stage III HCC

4 Malignant Liver Tumors
51
a
c
b
d
e
Fig. 4.12 Images of contrast enhanced ultrasound (CEUS) LR-5, denitely hepatocellular carcinoma (HCC), in a 54-year-old man with
hepatitis B-related cirrhosis. B mode ultrasound image showed a
37-mm diameter hypoechoic nodule in the right lobe of liver (a). Color
ow signals could be detected both inside the lesion and in the surrounding area of the lesion (b). The lesion showed heterogenously
f
hyperenhancement during arterial phase compared with the adjacent
liver (c) and reached peak enhancement in 18s after injection of contrast agents (d). Unequivocal slight contrast wash-out could be observed
during portal venous (e) and late phase (f). Subsequent surgery and histopathological results showed the lesion was a stage III HCC

52
Y. Dong et al.
a
b
c
d
Fig. 4.13 Images of contrast enhanced ultrasound (CEUS) LR-TIV,
hepatocellular carcinoma (HCC) with tumor thrombus, in a 49-year-old
man with hepatitis B-related cirrhosis. B mode ultrasound image
showed a large hypoechoic nodule in the right lobe of liver, hypoechoic
tumor thrombus was suspected inside the right branch of portal vein (a).
e
No color ow signals could be detected inside the portal vein (b). After
injection of contrast agents, real-time direct visualization of arterial
phase hyperenhancement in the tumor thrombus could be observed (c).
Hypoenhancement of thrombus could be observed during portal venous
(d) and late phase (e)

cd
4 Malignant Liver Tumors
53
a
b
e
f
Fig. 4.14 Images of contrast enhanced ultrasound (CEUS) LR-TIV,
hepatocellular carcinoma (HCC) with focal tumor thrombus, in a
79-year-old man with hepatitis B-related cirrhosis. B mode ultrasound
image showed a 21-mm focal hypoechoic tumor thrombus in the right
branch of portal vein (a). No color ow signals could be detected inside
the lesion (b). After injection of contrast agents, real-time visualization
of arterial phase hyperenhancement in the tumor thrombus could be
observed in 17s (c), 19s (d), 27s (e), and 32s (f) during arterial phase

54
de
Y. Dong et al.
a
b
c
Fig. 4.15 Hepatocellular carcinoma (HCC) with thrombus, in a
65-year-old man with hepatitis B-related cirrhosis. B mode ultrasound
image showed a large hypoechoic nodule in the right lobe of liver,
hypoechoic tumor thrombus was suspected inside the right branch of
portal vein (a). No color ow signals could be detected inside the portal
vein (b). After injection of contrast agents, a persistently nonenhancing
bland thrombus could be observed during arterial phase (c), portal
venous phase (d), and late phase (e)

a
b
4 Malignant Liver Tumors
55
c
e
g
d
f
h
Fig. 4.16 Nodule-in-nodule appearance. The patient is a 62-year-old
man with hepatitis B cirrhosis and an LR-5 lesion on B mode ultrasound (a). Contrast enhanced ultrasound showed a 24-mm nodule with
a nodule-in-nodule appearance in the arterial phase (arrows) (b–e). The
entire nodule displays hyperenhancement in the arterial phase, while an
extremely hyperenhanced nodular could be detected inside the lesion
(arrows) (b–e). On portal venous phase at 1min (f) and on late phase
after 4min (g), the lesion showed mild wash-out. Dynamic CEUS and
time intensity curves analysis also indicate different wash-in and washout mode between the nodule and the whole lesion (h). With regard to
surgery and histopathological appearance, this is typical of a poordifferentiated hepatocellular carcinoma (HCC) nodular developed in a
well-differentiated HCC lesion (i–k)

56
Y. Dong et al.
ki
j
Fig. 4.16 (continued)
Intraductal-growth type
The intraductal-growth type of ICC is conned within the
dilated part of an intrahepatic large bile duct. Tumor commonly shows a polypoid or papillary mural nodule within the
dilated bile duct lumen (Figs. 4.29 and 4.30). Sometimes
mild extension beyond bile duct walls can be seen. Ultrasound
can identify marked, localized dilatation of affected ducts.
Periductal-inltrating type
The periductal-inltrating type of ICC develops along the
intrahepatic bile ducts and appears as a solid mass extending
along portal tracts. As a result of tumoral obstruction, the
upstream ducts occur secondary dilatation (Fig.4.31). The
anatomical location of the involved ducts can be evaluated
by caliber changes or ducts rigidity. This type is hard to be
detected by ultrasound before surgery.
These three types may overlap in the same case. Advanced
ICC often has a mixed pattern of growth with central necrosis and/or intrahepatic metastases. Ultrasound can easily
detect secondary dilated bile ducts around the tumor
[16–18].
4.2.2.2 Contrast Enhanced Ultrasound Findings
Mass-forming type
ICCs with mass-forming type have a variety of patterns in
the arterial phase on contrast enhanced ultrasound (CEUS).
Peripheral rim-like hyperenhancement in the arterial phase is
the typical pattern (Fig.4.32) [19]. This typical pattern could
Соседние файлы в папке Библиотека им академика М.И. Перельмана
